Source: International Business Times
The updated labeling covers Mounjaro, Zepbound, Ozempic and Wegovy as investors assess whether the rare risk will affect prescriptions and sales. Scott Olson/Getty Images Eli Lilly and Novo Nordisk shares climbed Monday, outpacing the broader health care sector even as U. S.
Aller á la Source
Nouvelles connexes
